Xanidil may be available in the countries listed below.
Ingredient matches for Xanidil
Xantinol Nicotinate is reported as an ingredient of Xanidil in the following countries:
- Czech Republic
- Slovakia
International Drug Name Search
Xanidil may be available in the countries listed below.
Xantinol Nicotinate is reported as an ingredient of Xanidil in the following countries:
International Drug Name Search
Cyanocobalamin is reported as an ingredient of Vibisone in the following countries:
International Drug Name Search
See also: Generic Robaxin-750
Robaxin is a brand name of methocarbamol, approved by the FDA in the following formulation(s):
Yes. The following products are equivalent to Robaxin:
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Robaxin. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
There are no current U.S. patents associated with Robaxin.
Azmacort is a brand name of triamcinolone, approved by the FDA in the following formulation(s):
No. There is currently no therapeutically equivalent version of Azmacort available.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Azmacort. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
There are no current U.S. patents associated with Azmacort.
Miconazol KSK may be available in the countries listed below.
Miconazole nitrate (a derivative of Miconazole) is reported as an ingredient of Miconazol KSK in the following countries:
International Drug Name Search
Aminophylline Renaudin may be available in the countries listed below.
Aminophylline is reported as an ingredient of Aminophylline Renaudin in the following countries:
International Drug Name Search
Apitussic may be available in the countries listed below.
Sulfogaiacol is reported as an ingredient of Apitussic in the following countries:
International Drug Name Search
Fontula may be available in the countries listed below.
Dihydroergotoxine mesilate (a derivative of Dihydroergotoxine) is reported as an ingredient of Fontula in the following countries:
International Drug Name Search
Flupidol may be available in the countries listed below.
Penfluridol is reported as an ingredient of Flupidol in the following countries:
International Drug Name Search
Carbazochrome Sodium Sulfonate may be available in the countries listed below.
Carbazochrome Sodium Sulfonate (JAN) is also known as Carbazochrome (Rec.INN)
International Drug Name Search
Glossary
JAN | Japanese Accepted Name |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Tamoxifène G Gam may be available in the countries listed below.
Tamoxifen citrate (a derivative of Tamoxifen) is reported as an ingredient of Tamoxifène G Gam in the following countries:
International Drug Name Search
Generic Name: dexchlorpheniramine, methscopolamine, and phenylephrine (DEX klor fen IR a meen, METH skoe POL a meen, FEN il EFF rin)
Brand Names: DexPhen M, Extendryl, Re-Drylex
Dexchlorpheniramine is an antihistamine that reduces the natural chemical histamine in the body. Histamine can produce symptoms of sneezing, itching, watery eyes, and runny nose.
Methscopolamine is an anticholinergic (an-tye-kol-in-URJ-ik) that has a drying effect on the nasal passages.
Phenylephrine is a decongestant that shrinks blood vessels in the nasal passages. Dilated blood vessels can cause nasal congestion (stuffy nose).
The combination of dexchlorpheniramine, methscopolamine, and phenylephrine is used to treat runny nose, sneezing, itchy throat, watery eyes, and sinus congestion caused by allergies or the common cold.
This medication is also used to treat skin rash, hives, or swelling caused by an allergic reaction.
Dexchlorpheniramine, methscopolamine, and phenylephrine may also be used for other purposes not listed in this medication guide.
Before you take dexchlorpheniramine, methscopolamine, and phenylephrine, tell your doctor if you have a blockage in your stomach or intestines, kidney disease, diabetes, an enlarged prostate, problems with urination, or if you are over 40 years old.
glaucoma;
heart disease;
high blood pressure; or
a thyroid disorder.
If you have certain conditions, you may need a dose adjustment or special tests to safely use this medication. Before you take this medication, tell your doctor if you have:
a blockage in your stomach or intestines;
diabetes;
an enlarged prostate;
problems with urination; or
if you are over 40 years old;
Take this medication exactly as it was prescribed for you. Do not take the medication in larger amounts, or take it for longer than recommended by your doctor. Follow the directions on your prescription label. Cold medicine is usually taken for only a short time until your symptoms clear up.
Measure liquid medicine with a special dose-measuring spoon or cup, not a regular table spoon. If you do not have a dose-measuring device, ask your pharmacist for one.
This medication can cause you to have unusual results with allergy skin tests. Tell any doctor who treats you that you are taking an antihistamine.
Since cold or allergy medicine is usually taken only as needed, you may not be on a dosing schedule. If you are taking the medication regularly, take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose and take the medicine at your next regularly scheduled time. Do not take extra medicine to make up the missed dose.
Overdose symptoms may include nausea, vomiting, extreme drowsiness, confusion, weak or shallow breathing, and seizure (convulsions).
Avoid taking diet pills, caffeine pills, or other stimulants (such as ADHD medications) without your doctor's advice. Taking a stimulant together with a decongestant can increase your risk of unpleasant side effects.
slow heart rate;
fast, pounding, or uneven heartbeats;
severe dizziness, anxiety, restless feeling, or nervousness;
painful or difficult urination;
urinating less than usual or not at all; or
increased blood pressure (severe headache, blurred vision, trouble concentrating, chest pain, numbness, seizure).
Less serious side effects may include:
blurred vision;
dizziness, drowsiness, feeling irritable;
restlessness or excitability (especially in children);
dry mouth, trouble swallowing;
nausea, constipation; or
warmth, tingling, or redness under your skin.
This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.
Tell your doctor about all other medications you use, especially:
guanethidine (Ismelin);
mecamylamine (Inversine);
methyldopa (Aldomet);
reserpine; or
a beta-blocker such as atenolol (Tenormin), carvedilol (Coreg), esmolol (Brevibloc), labetalol (Normodyne, Trandate), metoprolol (Lopressor, Toprol), nadolol (Corgard), propranolol (Inderal, InnoPran), sotalol (Betapace), and others;
This list is not complete and there may be other drugs that can interact with dexchlorpheniramine, methscopolamine, and phenylephrine. Tell your doctor about all the prescription and over-the-counter medications you use. This includes vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start using a new medication without telling your doctor.
GIB ASS may be available in the countries listed below.
Acetylsalicylic Acid is reported as an ingredient of GIB ASS in the following countries:
International Drug Name Search
Tensoril may be available in the countries listed below.
Captopril is reported as an ingredient of Tensoril in the following countries:
International Drug Name Search
Cofamix STS may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Spiramycin embonate (a derivative of Spiramycin) is reported as an ingredient of Cofamix STS in the following countries:
Trimethoprim is reported as an ingredient of Cofamix STS in the following countries:
International Drug Name Search
Ophtazolin may be available in the countries listed below.
Antazoline sulfate (a derivative of Antazoline) is reported as an ingredient of Ophtazolin in the following countries:
Naphazoline nitrate (a derivative of Naphazoline) is reported as an ingredient of Ophtazolin in the following countries:
International Drug Name Search
Aspin-100 may be available in the countries listed below.
Acetylsalicylic Acid is reported as an ingredient of Aspin-100 in the following countries:
International Drug Name Search
Alprazolam Alternova may be available in the countries listed below.
Alprazolam is reported as an ingredient of Alprazolam Alternova in the following countries:
International Drug Name Search
Xeredien may be available in the countries listed below.
Fluoxetine hydrochloride (a derivative of Fluoxetine) is reported as an ingredient of Xeredien in the following countries:
International Drug Name Search
Furapill may be available in the countries listed below.
Furazolidone is reported as an ingredient of Furapill in the following countries:
International Drug Name Search
Rivacefin may be available in the countries listed below.
Ceftriaxone is reported as an ingredient of Rivacefin in the following countries:
International Drug Name Search
Mefenix may be available in the countries listed below.
Mefenamic Acid is reported as an ingredient of Mefenix in the following countries:
International Drug Name Search
Kalium Guajacolosulfonicum may be available in the countries listed below.
Sulfogaiacol is reported as an ingredient of Kalium Guajacolosulfonicum in the following countries:
International Drug Name Search
Lorazepam GenRx may be available in the countries listed below.
Lorazepam is reported as an ingredient of Lorazepam GenRx in the following countries:
International Drug Name Search
Nichfylin may be available in the countries listed below.
Aminophylline is reported as an ingredient of Nichfylin in the following countries:
International Drug Name Search
Griseofulvin Leo may be available in the countries listed below.
Griseofulvin is reported as an ingredient of Griseofulvin Leo in the following countries:
International Drug Name Search
Sodolac may be available in the countries listed below.
Etodolac is reported as an ingredient of Sodolac in the following countries:
International Drug Name Search
In some countries, this medicine may only be approved for veterinary use.
In the US, Erythrocin (erythromycin systemic) is a member of the drug class macrolides and is used to treat Bacterial Endocarditis Prevention, Bowel Preparation, Bronchitis, Bullous Pemphigoid, Campylobacter Gastroenteritis, Chancroid, Chlamydia Infection, Dental Abscess, Legionella Pneumonia, Lyme Disease, Lymphogranuloma Venereum, Mycoplasma Pneumonia, Nongonococcal Urethritis, Otitis Media, Pemphigoid, Pharyngitis, Pneumonia, Rheumatic Fever Prophylaxis, Skin Infection, Strep Throat, Syphilis - Early and Upper Respiratory Tract Infection.
US matches:
UK matches:
Erythromycin is reported as an ingredient of Erythrocin in the following countries:
Erythromycin ethylsuccinate (a derivative of Erythromycin) is reported as an ingredient of Erythrocin in the following countries:
Erythromycin lactobionate (a derivative of Erythromycin) is reported as an ingredient of Erythrocin in the following countries:
Erythromycin stearate (a derivative of Erythromycin) is reported as an ingredient of Erythrocin in the following countries:
Erythromycin thiocyanate (a derivative of Erythromycin) is reported as an ingredient of Erythrocin in the following countries:
International Drug Name Search
Glossary
SPC | Summary of Product Characteristics (UK) |
Narcan Neonatal may be available in the countries listed below.
Naloxone hydrochloride (a derivative of Naloxone) is reported as an ingredient of Narcan Neonatal in the following countries:
International Drug Name Search
Restandol Orifarm may be available in the countries listed below.
Testosterone undecanoate (a derivative of Testosterone) is reported as an ingredient of Restandol Orifarm in the following countries:
International Drug Name Search
Oramine may be available in the countries listed below.
Loratadine is reported as an ingredient of Oramine in the following countries:
International Drug Name Search
Gen-Cimetidine may be available in the countries listed below.
Cimetidine is reported as an ingredient of Gen-Cimetidine in the following countries:
International Drug Name Search
In some countries, this medicine may only be approved for veterinary use.
Rec.INN
A01AB03,B05CA02,D08AC02,D09AA12,R02AA05,S01AX09,S02AA09,S03AA04
0000055-56-1
C22-H30-Cl2-N10
505
Antiseptic
Disinfectant
2,4,11,13-Tetraazatetradecanediimidamide, N,N''-bis(4-chlorophenyl)-3,12-diimino-
International Drug Name Search
Glossary
BAN | British Approved Name |
BANM | British Approved Name (Modified) |
DCF | Dénomination Commune Française |
DCIT | Denominazione Comune Italiana |
IS | Inofficial Synonym |
OS | Official Synonym |
PH | Pharmacopoeia Name |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
In the US, Celestone Soluspan (betamethasone systemic) is a member of the drug class glucocorticoids and is used to treat Bursitis, Dermatological Disorders, Gouty Arthritis, Inflammatory Conditions and Osteoarthritis.
US matches:
Betamethasone 21-acetate and 21-(disodium phosphate) (a derivative of Betamethasone) is reported as an ingredient of Celestone Soluspan in the following countries:
International Drug Name Search
Tinidral may be available in the countries listed below.
Tinidazole is reported as an ingredient of Tinidral in the following countries:
International Drug Name Search
ral-OX-i-feen
Increased risk of deep vein thrombosis and pulmonary embolism have been reported. Avoid in women with active or past history of venous thromboembolism. Increased risk of death due to stroke occurred in a trial in postmenopausal women with documented coronary heart disease or at increased risk for major coronary events .
In the U.S.
Available Dosage Forms:
Therapeutic Class: Endocrine-Metabolic Agent
Pharmacologic Class: Selective Estrogen Receptor Modulator
Raloxifene is used to help prevent and treat thinning of the bones (osteoporosis) only in postmenopausal women.
It works like an estrogen to stop the bone loss that can develop in women after menopause, but it does not increase the bone density as much as daily 0.625 mg doses of conjugated estrogens. Raloxifene will not treat hot flashes of menopause and may cause hot flashes to occur. Also, raloxifene does not stimulate the breast or uterus as estrogen does.
Raloxifene lowers the blood concentrations of total and low-density lipoprotein (LDL) cholesterol, the bad cholesterols, but it does not increase concentrations of high-density lipoprotein (HDL) cholesterol, the good cholesterol, in your blood.
Raloxifene is also used to lower chances of having invasive breast cancer in postmenopausal women with osteoporosis or at high risk of having invasive breast cancer .
raloxifene is available only with your doctor's prescription.
Once a medicine has been approved for marketing for a certain use, experience may show that it is also useful for other medical problems. Although these uses are not included in product labeling, raloxifene is used in certain patients with the following medical conditions:
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For raloxifene, the following should be considered:
Tell your doctor if you have ever had any unusual or allergic reaction to raloxifene or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
raloxifene has been tested only in women past menopause and has not been shown to cause different side effects or problems in elderly people than it does in adults who have just gone through menopause.
Pregnancy Category | Explanation | |
---|---|---|
All Trimesters | X | Studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities. This drug should not be used in women who are or may become pregnant because the risk clearly outweighs any possible benefit. |
There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.
Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.
The presence of other medical problems may affect the use of raloxifene. Make sure you tell your doctor if you have any other medical problems, especially:
A paper with information for the patient will be given to you with your filled prescription, and will provide many details concerning the use of raloxifene. Read this paper carefully and ask your health care professional if you need additional information or explanation.
Many patients trying to prevent or treat bone loss will not notice any signs of the problem. In fact, many may feel normal. It is very important that you take your medicine exactly as directed.
The dose of raloxifene will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of raloxifene. If your dose is different, do not change it unless your doctor tells you to do so.
The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.
If you miss a dose of raloxifene, skip the missed dose and go back to your regular dosing schedule. Do not double doses.
Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.
Keep out of the reach of children.
Do not keep outdated medicine or medicine no longer needed.
Ask your healthcare professional how you should dispose of any medicine you do not use.
It is very important that you keep your appointments with your doctor even if you feel well.
Before you have any kind of surgery, tell the medical doctor in charge that you are using raloxifene. Discuss discontinuing use of raloxifene 3 days before you think you will have a long period of inactivity, sitting, or bed rest, such as after having surgery or going on a long trip. The doctor may have you start the medicine again after you are back on your feet and fully mobile. If you are going on a trip and stay on raloxifene, you should walk regularly or move about when possible. Remaining still for long periods may cause blood clots for some people, and raloxifene may rarely worsen their condition.
If you are able to become pregnant, stop using the medicine immediately if you think you have become pregnant and check with your doctor. Raloxifene is recommended for women who are past menopause.
Raloxifene does not act like an estrogen to stimulate the uterus or breast. If you experience vaginal bleeding, breast pain or enlargement, or swelling of hands or feet while on raloxifene, you should report it to your doctor.
Other ways that may be used with raloxifene to help prevent or treat bone loss are taking calcium plus vitamin D supplements and getting weight-bearing exercise. You may want to discuss these options with your doctor.
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Stop taking raloxifene and get emergency help immediately if any of the following effects occur:
Check with your doctor as soon as possible if any of the following side effects occur:
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
See also: raloxifene side effects (in more detail)
The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.
The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.